Valeriana hepatotoxicity

Sleep Medicine

Volumn 10, Issue 8, 2009, Pages 935-

  Vassiliadis, Themistoklis ^a   Anagnostis, Panagiotis ^a   Patsiaoura, Kalliopi ^a   Giouleme, Olga ^a   Katsinelos, Panagiotis ^b   Mpoumponaris, Alexandros ^a   Eugenidis, Nikolaos ^a  

^a Aristotle University and Hippokration General Hospital   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

VALERIAN;

ADULT; BLOOD EXAMINATION; CASE REPORT; CAUCASIAN; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER FUNCTION TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TEA; TOXIC HEPATITIS; VALERIANA;

ACUTE DISEASE; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MIDDLE AGED; PLANT PREPARATIONS; SLEEP INITIATION AND MAINTENANCE DISORDERS; VALERIAN;

EID: 68749097179     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.09.009     Document Type: Letter

References (6)

1. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 22 (2002) 195-206
2. Hadley S., and Petry J.J. Valerian. Am Fam Physician 67 (2003) 1755-1758
3. Stevinson C., and Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med 1 (2000) 91-99
4. Taibi D, Vitiello M, Barsness S, Elmer G, Anderson G, Landis C. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia. Sleep Med; 2008 [epub ahead of print].
5. Riedel E., Hansel R., and Ehrke G. Inhibition of gamma-aminobutyric acid catabolism by valerenic acid derivatives. Planta Med 46 (1982) 219-220
6. Lefebvre T., Foster B.C., Drouin C.E., Krantis A., Livesey J.F., and Jordan S.A. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J Pharm Pharm Sci 7 (2004) 265-273